GB201106825D0 - Nanoparticles - Google Patents

Nanoparticles

Info

Publication number
GB201106825D0
GB201106825D0 GB201106825A GB201106825A GB201106825D0 GB 201106825 D0 GB201106825 D0 GB 201106825D0 GB 201106825 A GB201106825 A GB 201106825A GB 201106825 A GB201106825 A GB 201106825A GB 201106825 D0 GB201106825 D0 GB 201106825D0
Authority
GB
United Kingdom
Prior art keywords
composite material
porous composite
hydrophobic
nanoparticles
magnetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201106825A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Liverpool
Original Assignee
University of Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Liverpool filed Critical University of Liverpool
Priority to GB201106825A priority Critical patent/GB201106825D0/en
Publication of GB201106825D0 publication Critical patent/GB201106825D0/en
Priority to PCT/GB2012/050884 priority patent/WO2012143733A1/en
Ceased legal-status Critical Current

Links

Abstract

The present invention relates to a porous composite material comprising a hydrophilic carrier carrying a magnetic material. The porous composite material can include a hydrophobic polymer, hydrophobic material, organic compound, and/or pharmaceutically active ingredient. The porous composite material is prepared by a modified emulsion templating and freeze-drying procedure. Magnetic nanoparticles are released from the porous composite material on application of water.
GB201106825A 2011-04-21 2011-04-21 Nanoparticles Ceased GB201106825D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201106825A GB201106825D0 (en) 2011-04-21 2011-04-21 Nanoparticles
PCT/GB2012/050884 WO2012143733A1 (en) 2011-04-21 2012-04-20 Nanoparticles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201106825A GB201106825D0 (en) 2011-04-21 2011-04-21 Nanoparticles

Publications (1)

Publication Number Publication Date
GB201106825D0 true GB201106825D0 (en) 2011-06-01

Family

ID=44147405

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201106825A Ceased GB201106825D0 (en) 2011-04-21 2011-04-21 Nanoparticles

Country Status (2)

Country Link
GB (1) GB201106825D0 (en)
WO (1) WO2012143733A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018064150A1 (en) * 2016-09-29 2018-04-05 The University Of Memphis Research Foundation Microbead compositions and methods for delivering an agent
US20230166989A1 (en) * 2021-11-26 2023-06-01 Giftedness And Creativity Company System and method for separating water from oil

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2399084B (en) 2002-07-30 2007-01-31 Univ Liverpool Porous beads and method of production thereof
US8242182B2 (en) 2004-01-28 2012-08-14 Iota Nanosolutions Limited Porous bodies and method of production thereof
GB0401947D0 (en) 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
GB0401950D0 (en) 2004-01-28 2004-03-03 Unilever Plc Porous bodies and method of production thereof
GB2454931A (en) 2007-11-26 2009-05-27 Univ Liverpool Use of clathrates in gas storage

Also Published As

Publication number Publication date
WO2012143733A1 (en) 2012-10-26

Similar Documents

Publication Publication Date Title
CL2013002504A1 (en) Solid coated pharmaceutical preparation comprising at least one active ingredient and because the coating has a thickness of 0.1 to 100 nm, preferably 0.3 to 50 nm and more preferably 0.5 to 35 nm; and its method of preparation
WO2012131463A3 (en) Controlled release pharmaceutical dosage forms
WO2010096733A3 (en) Luminescent porous silicon nanoparticles, methods of making and using same
WO2011143206A3 (en) Porous materials, methods of making and uses
MX2016004759A (en) Compositions of lean nox trap.
MX363961B (en) Polymeric finasteride and minoxidil nanoparticles, method for preparing same, aqueous suspension containing same, pharmaceutical composition and use thereof.
MX2014011181A (en) Cyclodextrin-based microemulsions, and dermatological uses thereof.
WO2012048176A3 (en) Attachment and retention formulations for biologically active organic compounds
EA201390885A1 (en) AZAINDOLS AS ANTI-VIRAL AGENTS AGAINST THE RESPIRATORY SYNCTIAL VIRUS
UY35003A (en) FINASTERIDA POLYMERIC NANOPARTICLE, WATERPROOF SUSPENSION CONTAINING THE SAME, COMPOSITION FOR ALOPECIA TREATMENT, SUCH COMPOSITION PREPARATION PROCESS, AND ITS USE
EA201290497A1 (en) THERAPEUTIC POLYMERIC NANOPARTICLES, INCLUDING CORTICOSTEROIDS, AND METHODS OF OBTAINING SUCH
MY163083A (en) Solid forms of a pharmaceutically active substance
EA201170962A1 (en) PREPARATION OF RAZAGILINA WITH AN ADDED TREATMENT
WO2011049309A3 (en) Pharmaceutical composition with both immediate and extended release characteristics
BR112014010900A2 (en) methods of preparing catalyst system
EA201290498A1 (en) THERAPEUTIC POLYMER NANOPARTICLES, INCLUDING EPOTILON, AND METHODS FOR THEIR PREPARATION AND APPLICATION
CY1124331T1 (en) INCREASED BIOAVAILABILITY OF ACTIVE SUBSTANCE IN NALTREXONE THERAPY
CL2012002124A1 (en) Rifaximin powder comprising a particle size between 40 and 120 micrometers; controlled release compositions containing said rifaximin and its preparation process, useful for the treatment of bacterial intestinal infections.
UA112540C2 (en) A FILM MEDICINAL FORM CONTAINING THE FREE SILDENAFIL BASE AND THE METHOD OF OBTAINING THIS
WO2011121560A3 (en) Stabilized antibody preparations and uses thereof
WO2013123138A3 (en) Spiro [2.4]heptanes for treatment of flaviviridae infections
WO2012014078A3 (en) Method of treatment of organic diseases of nervous system, psychoorganic syndrome and encephalopathy
MY160372A (en) Composition for improving brain function and method for improving brain function
WO2012040331A3 (en) Multistage nanoparticles
UY33993A (en) MACROCYCLIC ANALOG OF SANGLIFERINA AND ITS PRODUCTION METHOD

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)